Early trials of HIV post-exposure prophylaxis (PEP) often used single drugs. There is no evidence from human studies to suggest that this is inferior to combination treatment. However, many experts believe that using more than one drug may reduce the risk of HIV transmission, as this produces better results in patients with established HIV infection. Using more than one drug also covers the possibility that the patient could have been exposed to a strain of virus that is resistant to one or more drugs.